Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in obese children and adolescents with insulin resistance
2010-023980-17Phase 3Active
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and insulin resistance (IR) comparing Metformin + lifestyle intervention with Placebo + lifestyle intervention (2 arms). Primary endpoint: Reduction in BMI. Started Jul 2011; status: active.
02
Drugs
metformin
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on 2010-023980-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023980-17.